• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Inspire Veterinary Partners Inc.

    6/20/25 8:21:23 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $IVP alert in real time by email
    S-8 1 ea0246135-s8_inspire.htm REGISTRATION STATEMENT

    As filed with the Securities and Exchange Commission on June 20, 2025.

    Registration No. 333-                       

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

    INSPIRE VETERINARY PARTNERS INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada   85-4359258
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    780 Lynhaven Parkway, Suite 400

    Virginai Beach, VA 23452

    (Address of Principal Executive Offices)

     

    Inspire Veterinary Partners, Inc. 2022 Equity Incentive Plan

    (Full title of the plan)

     

    Mark E. Crone, Esq.

    The Crone Law Group, P.C.

    420 Lexington Avenue, Suite 2446

    New York, NY 10170

    (Name and address of agent for service)

     

    757-734-5464

    (Telephone number, including area code, of agent for service)

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

     

    ☐ Large accelerated filer ☐ Accelerated filer
    ☒ Non-accelerated filer ☒ Smaller reporting company
    ☒ Emerging growth company  

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement is being filed by Inspire Veterinary Partners, Inc., a Nevada corporation (the “Company”), in accordance with the requirements of Form S-8 under the Securities Act of 1933, as amended (the “Securities Act”). The Company’s 2022 Equity Incentive Plan (the “2022 Plan”), which was adopted by the board of directors and approved by the shareholders of the Company on October 18, 2022, allows for issuances not to exceed 10% of the authorized shares of the Company. We are registering 10,000,000 shares of Class A common stock of the Company, par value $0.0001 per share, issuable pursuant to the 2022 Plan which represents 10% of the authorized shares of the Company at the time of this Registration Statement.

     

     

     

     

    PART I

     

    INFORMATION REQUIRED IN SECTION 10(a) PROSPECTUS

     

    Item 1. Plan Information.*

     

    Item 2. Registrant Information and Employee Plan Annual Information.*

     

    Information required by Part I to be contained in Section 10(a) prospectus is omitted from the Registration Statement in accordance with Rule 428 under the Securities Act of 1933, and Note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the Equity Incentive Plan covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act.

     

    1

     

     

    PART II

     

    Item 3. Incorporation of Documents by Reference.

     

    The following documents filed by the Company with the Securities and Exchange Commission (the “Commission”) are incorporated by reference into this Registration Statement:

     

    1.The registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 31, 2025 (File Number: 001-41792) (the “2024 Form 10-K”);

     

    2.The registrant’s Quarterly Reports on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 15, 2025;

     

    3.All other reports filed by the registrant with the Commission pursuant to Sections 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Form 10-K (other than the portions of these documents not deemed to be filed); and

     

    4.the description of the Class A common stock contained in the registrant’s registration statement on Form 8-A filed with the SEC on August 29, 2023, including any amendments or reports filed for the purposes of updating this description, including Exhibit 4.2 to the 2024 Form 10-K.; and

     

    All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents.

     

    Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 4. Description of Securities.

     

    Not Applicable

     

    Item 5. Interests of Named Experts and Counsel.

     

    No expert or counsel named in this prospectus as having prepared or certified any part of it or as having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the Common Stock was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial interest, direct or indirect, in the Company or any of its parents or subsidiaries. Nor was any such person connected with the Company or any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.

     

    Item 6. Indemnification of Directors and Officers.

     

    Section 78.7502 of the Nevada Revised Statutes provides that a Nevada corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he is not liable under Section 78.138 of the Nevada Revised Statutes for breach of his or her fiduciary duties to the corporation or he acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

     

    II-1

     

     

    Section 78.7502 further provides a Nevada corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he is not liable under Section 78.138 of the Nevada Revised Statutes for breach of his or her fiduciary duties to the corporation or he acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper. To the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any non-derivative proceeding or any derivative proceeding, or in defense of any claim, issue or matter therein, the corporation shall indemnify him or her against expenses, including attorneys’ fees, actually and reasonably incurred in connection with the defense. Further, Nevada law permits a Nevada corporation to purchase and maintain insurance or to make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise for any liability asserted against him or her and liability and expenses incurred by him or her in his or her capacity as a director, officer, employee or agent, or arising out of his or her status as such, whether or not the corporation has the authority to indemnify him or her against such liability and expenses.

     

    The amended and restated articles of incorporation and the amended and restated bylaws of the Company provide that the Company shall, to the fullest extent permitted by the NRS, as now or hereafter in effect, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the Company, by reason of the fact that he is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (i) is not liable pursuant to NRS Section 78.138; or (ii) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

     

    II-2

     

     

    Item 7.Exemption from Registration Claimed.

     

    Not applicable.

     

    Item 8.Exhibits.

     

    Exhibit Number   Description
    5.1   Opinion of The Crone Law Group regarding validity of securities with consent to use
    10.1   2022 Equity Incentive Plan
    23.1   Consent of Kreit & Chiu CPA LLP
    24.1   Power of Attorney
    107   Filing Fee Table

     

    Item 9.Undertakings.

     

    A. The undersigned registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    (ii)  To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment hereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

     

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in this registration statement.

     

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    II-3

     

     

    (4) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

     

    (i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

     

    (ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

     

    (iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

     

    (iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

     

    B. The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    II-4

     

     

    SIGNATURES

     

    In accordance with the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and authorized this registration statement to be signed on its behalf by the undersigned, in the state of Nevada, on June 20, 2025.

     

    Inspire Veterinary Partners, Inc.  
         
    By: /s/ Kimball Carr  
      Kimball Carr  
      Chief Executive Officer and Chairman  
      (Principal Executive Officer and Principal Financial and Accounting Officer)  

     

    POWER OF ATTORNEY

     

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John Keeler as his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of them, or of their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates stated.

     

    /s/ Kimball Carr   Chair, President and Chief Executive Officer   June 20, 2025
    Kimball Carr   (Principal Executive Officer)    
             
    /s/ Richard Frank   Chief Financial Officer, Director   June 20, 2025
    Richard Frank   (Principal Financial Officer)    
             
    /s/ Larry Alexander   Director   June 20, 2025
    Larry Alexander        
             
    /s/ Charles Stith Keiser   Director   June 20, 2025
    Charles Stith Keiser        
             
    /s/ Phillip Balatsos   Director   June 20, 2025
    Phillip Balatsos        
             
    /s/ Anne Murphy   Director   June 20, 2025
    Anne Murphy        
             

    /s/ Erinn Thomas-Mackey, DMV

     

    Director

      June 20, 2025
    Erinn Thomas-Mackey, DMV        
             
    /s/ Timothy Watters   Director   June 20, 2025
    Timothy Watters        

     

    II-5

    Get the next $IVP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $IVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Watters Timothy sold $85 worth of shares (467 units at $0.18), closing all direct ownership in the company (SEC Form 4)

      4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      12/30/24 3:32:49 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Large owner Alomari Ahmed sold $497,640 worth of shares (50,000 units at $9.95), decreasing direct ownership by 33% to 100,000 units (SEC Form 4)

      4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      7/17/24 8:50:08 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • New insider Alomari Ahmed claimed ownership of 150,000 shares (SEC Form 3)

      3 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      7/17/24 8:49:11 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results

      VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.Select Third Quarter 2024 Highlights Compared to Prior Year PeriodTotal revenue of approximately $4.0 million, a decrease of 1.7%Services revenue of $2.9 million, an increase of 1%Product revenue of $1.1 million, a decrease of 9%G&A decreased 16%Net loss decreased 56%Total revenue of approximately $13.3 million, an increase of 3%Services revenue of approximately $9.7 million, an increase of 6%Pr

      11/13/24 5:56:00 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

      NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is proud to announce its successful completion of several notable transactions throughout October 2024. The deals demonstrate Spartan's expertise and unwavering commitment to supporting clients' growth and capital needs across diverse sectors. In October, Spartan Capital Securities served as the placement agent for 1847 Holdings LLC's follow-on offering, raising $11,099,985. This capital infusion will enable 1847 Holdings LLC (NYSE:EFSH), a diversified holding company, to continue its growth strategy, enhance operational flexibility, and pursue acquisition opportunit

      11/1/24 2:36:24 PM ET
      $EFSH
      $IVP
      $TPET
      Professional Services
      Consumer Discretionary
      Farming/Seeds/Milling
      Consumer Staples
    • Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

      New York, NY, Oct. 28, 2024 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Inspire Veterinary Partners, Inc.'s (NASDAQ:IVP) $2.5 million registered direct offering of Class A common stock. Inspire Veterinary Partners, a provider of veterinary healthcare services throughout the U.S., has entered into a securities purchase agreement with institutional investors to sell 10,000,000 shares of Class A common stock at a price of $0.25 per share. The offering is expected to generate gross proceeds of $2.5 million, before deducting placement agent fees and other related expenses. The company pl

      10/28/24 4:36:58 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    SEC Filings

    See more
    • SEC Form S-1 filed by Inspire Veterinary Partners Inc.

      S-1 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      7/7/25 7:45:47 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form S-8 filed by Inspire Veterinary Partners Inc.

      S-8 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      6/20/25 8:21:23 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Inspire Veterinary Partners Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Other Events

      8-K - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      6/10/25 3:30:57 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Leadership Updates

    Live Leadership Updates

    See more
    • Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

      VIRGINIA BEACH, VA / ACCESSWIRE / August 27, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a non-binding letter of intent (the "LOI") with Vetsie.ai, an Artificial Intelligence ("AI") software platform designed to empower veterinary professionals with quick, accurate access to critical information on patient conditions, treatments, and medications, to engage in diligence and initial negotiations regarding the terms of a potential transaction whereby Inspire may Acquire Vetsie.ai in an all- stock transaction. This potential equity-only acquisiti

      8/27/24 8:30:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

      VIRGINIA BEACH, VA / ACCESSWIRE / August 16, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that its board of directors has nominated Phillip Balatsos to stand for election as an independent director at its annual meeting of stockholders on October 9, 2024.Mr. Balatsos has served as the Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading with XP Investments US Inc. since August 2022. Mr. Balatsos provides coverage and execution of currency trading in emerging markets as well as commodity and fixed income products and derivatives for global macro hedg

      8/16/24 8:30:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Financials

    Live finance-specific insights

    See more
    • Inspire Veterinary Partners Announces Acquisition of Valley Veterinary Service Animal Hospital

      Latest acquisition brings the total number of Inspire locations to 14.Expansion into a new state, Pennsylvania.Pipeline of attractive potential acquisitions of animal hospitals remains active.VIRGINIA BEACH, VA / ACCESSWIRE / November 8, 2023 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has completed the acquisition of Valley Veterinary Service, Inc. animal hospital located in Pennsylvania, Inspire's first entry in that state.Valley Veterinary Service's 2022 gross revenues were in excess of $1.7 million. As part of the transaction, Inspire acquired certain real est

      11/8/23 2:00:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Inspire Veterinary Partners Inc.

      SC 13G/A - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

      10/11/24 4:05:57 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form SC 13G filed by Inspire Veterinary Partners Inc.

      SC 13G - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

      7/19/24 9:30:47 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples